- Home
- CAPR vs LAW Comparison
CAPR vs LAW Comparison
Compare CAPR & LAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAPR
- LAW
- Stock Information
- Founded
- CAPR 2005
- LAW 2013
- Country
- CAPR United States
- LAW United States
- Employees
- CAPR N/A
- LAW N/A
- Industry
- CAPR Biotechnology: Biological Products (No Diagnostic Substances)
- LAW Computer Software: Prepackaged Software
- Sector
- CAPR Health Care
- LAW Technology
- Exchange
- CAPR Nasdaq
- LAW Nasdaq
- Market Cap
- CAPR 332.5M
- LAW 356.9M
- IPO Year
- CAPR N/A
- LAW 2021
- Fundamental
- Price
- CAPR $19.65
- LAW $5.98
- Analyst Decision
- CAPR Strong Buy
- LAW Hold
- Analyst Count
- CAPR 6
- LAW 5
- Target Price
- CAPR $35.50
- LAW $7.10
- AVG Volume (30 Days)
- CAPR 1.9M
- LAW 105.3K
- Earning Date
- CAPR 11-13-2024
- LAW 11-06-2024
- Dividend Yield
- CAPR N/A
- LAW N/A
- EPS Growth
- CAPR N/A
- LAW N/A
- EPS
- CAPR N/A
- LAW N/A
- Revenue
- CAPR $27,152,218.00
- LAW $143,584,000.00
- Revenue This Year
- CAPR N/A
- LAW $6.13
- Revenue Next Year
- CAPR $135.53
- LAW $6.26
- P/E Ratio
- CAPR N/A
- LAW N/A
- Revenue Growth
- CAPR 187.15
- LAW 6.45
- 52 Week Low
- CAPR $2.68
- LAW $4.71
- 52 Week High
- CAPR $23.40
- LAW $8.80
- Technical
- Relative Strength Index (RSI)
- CAPR 53.80
- LAW 53.16
- Support Level
- CAPR $17.50
- LAW $5.94
- Resistance Level
- CAPR $20.37
- LAW $6.58
- Average True Range (ATR)
- CAPR 1.57
- LAW 0.19
- MACD
- CAPR -0.73
- LAW 0.01
- Stochastic Oscillator
- CAPR 24.91
- LAW 32.93
About CAPR Capricor Therapeutics Inc.
Capricor Therapeutics Inc is a United States-based biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy and other medical conditions. The company's development stage product pipeline includes CAP-1002, for Duchenne Muscular Dystrophy Program and COVID-19 Program; CDC-Exosomes (CAP-2003); and Exosome-mRNA vaccine.
About LAW CS Disco Inc.
CS Disco Inc provides a cloud-native, artificial intelligence-powered legal solution that simplifies discovery, legal document review, and case management for enterprises, law firms, legal services providers, and governments. Its revenue-generating activities directly relate to the sale and support of legal solutions. It has two primary types of contractual arrangements: usage-based and subscription solutions. The usage-based revenue is derived from contracts under which customers are billed monthly based on their usage. Subscription revenue is derived from contracts where customers are contractually committed to a minimum data volume over a period of time.